France Photodynamic Therapy Market Outlook

france is one of europe’s largest markets for photodynamic therapy (pdt) applications. france’s photodynamic therapy market is expected to experience a gradual growth trend over the forecast period (2018-2032). the demand for pdt in france is mainly driven by the growing incidence of cancer, especially when it comes to treating non-melanoma skin cancers, such as basal cell and squamous cell carcinomas. in addition, france is likely to benefit from the increasing availability of some newer pdt treatments such as photofrin pdt, which is widely used to treat non-malignant and malignant skin disorders, as well as dysplastic lesions. moreover, the increasing usage of advanced photodynamic therapies such as light-emitting diode pdt, and related led technologies, is expected to create further opportunities for the market going forward. furthermore, global technological advancements, coupled with the development of photodynamic drugs and light sources, is set to fuel the growth of the photodynamic therapy market in france. customers are likely to be influenced by the modernity of the technology, as well as its effectiveness in treating specific medical conditions. in the current scenario, pdt is also being used to treat conditions such as age-related macular degeneration, actinic keratosis, and acne. the french healthcare system is highly accessible and well-developed. the prevalence of modern healthcare systems and the widespread availability of photodynamic treatments from specialty clinics, has resulted in growing awareness and adoption of pdt, in france. this is, in turn, likely to fuel the demand for pdt during the forecast period. finally, an increase in research and development activities to enhance the efficacy, safety and cost-effectiveness of photodynamic treatments, as well as their quick commercialization, is expected to create further opportunities for the market in france.